Autologous stem cell transplant for relapsed and refractory peripheral T-cell lymphoma: Variable outcome according to pathological subtype

British Journal of Haematology

Volumn 120, Issue 6, 2003, Pages 978-985

  Song, Kevin W ^a   Mollee, Peter ^a   Keating, Armand ^a   Crump, Michael ^a,b  

^a UNIVERSITY OF TORONTO   (Canada)

^b PRINCESS MARGARET HOSPITAL   (Canada)

Author keywords

Autologous stem cell transplantation; Pathology; Peripheral T cell lymphoma; Relapse

Indexed keywords

ETOPOSIDE; MELPHALAN;

ADULT; AGED; ARTICLE; B CELL LYMPHOMA; CANCER SURVIVAL; CHEMOSENSITIVITY; COHORT ANALYSIS; CONTROLLED STUDY; DOSE RESPONSE; DRUG MEGADOSE; FEMALE; FOLLOW UP; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMAN; IRRADIATION; MAJOR CLINICAL STUDY; MALE; NULL CELL; PERIPHERAL T CELL LYMPHOMA; PRIORITY JOURNAL; PROGNOSIS; STATISTICAL ANALYSIS; STEM CELL; TREATMENT OUTCOME;

ADULT; AGED; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CHI-SQUARE DISTRIBUTION; DISEASE-FREE SURVIVAL; ETOPOSIDE; FEMALE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; LYMPHOMA, LARGE-CELL, DIFFUSE; LYMPHOMA, T-CELL, PERIPHERAL; MALE; MELPHALAN; MIDDLE AGED; RECURRENCE; RETROSPECTIVE STUDIES; SALVAGE THERAPY; SURVIVAL RATE; TRANSPLANTATION CONDITIONING; TRANSPLANTATION, AUTOLOGOUS;

EID: 0037355624     PISSN: 00071048     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2141.2003.04203.x     Document Type: Article

References (32)

1. Anonymous (1997) A clinical evaluation of the International Lymphoma Study Group classification of non-Hodgkin's lymphoma. The Non-Hodgkin's Lymphoma Classification Project. Blood, 89, 3909-3918.
2. Armitage, J.O. (1993) Treatment of non-Hodgkin's lymphoma. New England Journal of Medicine, 328, 1023-1030.
3. Blay, J., Gomez, F., Sebban, C., Bachelot, T., Biron, P., Guglielmi, C., Hagenbeek, A., Somers, R., Chauvin, F. & Philip, T. (1998) The International Prognostic Index correlates to survival in patients with aggressive lymphoma in relapse: analysis of the PARMA trial. Blood, 92, 3562-3568.
4. Blystad, A.K., Enblad, G., Kvaloy, S., Berglund, A., Delabie, J., Holte, H., Carleson, K., Kvalhein, G., Bengtsson, M. & Hagberg, H. (2001) High-dose therapy with autologous stem cell transplantation in patients with peripheral T cell lymphomas. Bone Marrow Transplantation, 27, 711-716.
5. Cheson, B.D., Homing, S.J., Coiffier, B., Shipp, M.A., Fisher, R.I., Connors, J.M., Lister, T.A., Vose, J., Grillo-Lopez, A., Hagenbeek, A., Cabanillas, F., Klippensten, D., Hiddemann, W., Castellino, R., Harris, N.L., Armitage, J.O., Carter, W., Hoppe, R. & Canellos, G.P. (1999) Report of an international workshop to standardize response criteria for non-Hodgkin's lymphomas. NCI Sponsored International Working Group. Journal of Clinical Oncology, 17, 1244.
6. Conover, W. (1980) Practical Nonparametreic Statistics. Wiley, New York.
7. Crump, M., Smith, A.M., Brandwein, J., Couture, F., Sherret, H., Sutton, D.M.C., Scott, J.G., McCrae, J., Murray, C., Pantalony, D., Sutcliffe, S.B. & Keating, A. (1993) High dose etoposide, melphalan, and autologous bone marrow transplantation for patients with advanced Hodgkin's disease: importance of disease status at transplant. Journal of Clinical Oncology, 11, 704-711.
8. Fanin, R., Ruiz de Elvira, M.C., Sperotto, A., Baccarani, M. & Goldstone, A. (1999) Autologous stem cell transplantation for T and null cell CD30-positive anaplastic large cell lymphoma: analysis of 64 adult and paediatric cases reported to the European Group for Blood and Marrow Transplantation (EBMT). Bone Marrow Transplantation, 23, 437-442.
9. Girouard, C., Dufresne, J., Imrie, K., Stewart, A.K., Brandwein, J., Prince, H.M., Pantalony, D., Keating, A. & Crump, M. (1997) Salvage chemotherapy with mini-BEAM for relapsed or refractory non-Hodgkin's lymphoma prior to autologous bone marrow transplantation. Annals of Oncology, 8, 675-680.
10. Gisselbrecht, C., Gaulard, P., Lepage, E., Coiffier, B., Briere, J., Haioun, C., Cazals-Hatem, D., Bosly, A., Xerri, L., Tilly, H., Berger, F., Bouhabdallah, R. & Diebold, J. (1998) Prognostic significance of T-cell phenotype in aggressive non-Hodgkin's lymphomas. Groupe d'Etudes des Lymphomes de l'Adulte (GELA). Blood, 92, 76-82.
11. Hahn, T., Wolff, S.N., Czuczman, M., Fisher. R.L., Lazarus, H.M., Vose, J., Warren, L., Watt, R. & McCarthy, Jr, P.L. (2001) The role of cytotoxic therapy with hematopoietic stem cell transplantation in the therapy of diffuse large cell B-cell non-Hodgkin's lymphoma: an evidence-based review. Biology of Blood Marrow Transplantation, 7, 308-331.
12. Haider, K., Zamkoff, K. & Gentile, T. (1999) High dose chemotherapy and autologous stem cell transplant in peripheral T-cell lymphoma. A single institution experience. Blood, 94, 173a.
13. Haloun, C., Lepage, E., Gisselbrecht, C., Salles, G., Coiffier, B., Brice, P., Bosly, A., Morel, P., Nouvel, C., Tilly, H., Lederlin, P., Sebban, C., Briere, J., Gaulard, P. & Reyes, F. (2000) Survival benefit of high-dose therapy in poor-risk aggressive non-Hodgkin's lymphoma: a final analysis of the prospective LNH87-2 protocol. A Groupe d'Etude des Lymphomes de l'Adulte study. Journal of Clinical Oncology, 18, 3025-3030.
14. Harris, N.L., Jaffe, E.S., Stein, H., Banks, P.M., Chan, J.K., Cleary, M.L., Delsol, G., De Wolfe-Peeters, C., Falini, B. & Gatter, K.C. (1994) A revised European-American classification of lymphoid neoplasms: a proposal from the International Lymphoma Study Group. Blood. 84, 1361-1392.
15. Harris, N.L., Jaffe, E.S., Diebold, J., Flandrin, G., Muller-Hermelink, H.K., Vardiman, J., Lister, T.A. & Bloomfield, C.D. (1999) The World Health Organization classification of neoplastic diseases of the hematopoietic and lymphoid tissues: report of the Clinical Advisory Committee meeting. Airlie House, Virginia, November 1997. Journal of Clinical Oncology, 17, 3835-3849.
16. Jagasia, M., Stein, R., Kinney, M., Goodman, S., Wolff, S., Morgan, D., Schuening, F. & Greer, J. (2001) High dose chemotherapy and hematopoietic stem cell transplant in peripheral T cell, NK cell and Ki-1 anaplastic large cell lymphoma. Proceedings of the American Society of Clinical Oncology, 20, 294a.
17. Kaplan, E. & Meier, P. (1958) Nonparametric estimation from incomplete observations. Journal of the American Statistical Association, 53, 157-181.
18. Kewalramani, T., Zelenetz, A.D., Hedrick, E.E., Donnelly, G.B., Hunte, S., Priovolos, A.C., Qin, J., Lyons, N.C., Yahalom, J., Nimer, S.D. & Moskowitz, C.H. (2000) High-dose chemoradiotherapy and autologous stem cell transplantation for patients with primary refractory aggressive non-Hodgkin lymphoma: an intention-to-treat analysis. Blood, 96, 2399-2404.
19. Kingreen, D., Reichle, A., Fetscher, S., Berdel, E., Beguin, Y., Brunet, S., Caballero, D., DeLaurenzi, A., Hagberg, H., Johnson, H., Kimby, E. & Lopez-Siegert, A. (1999) High dose chemotherapy with autologous stem cell transplant in patients with angio-immunoblastic T-cell lymphoma (AILD). Blood, 94, 172a.
20. Kluin-Nelemans, H., Zagonel, V., Anastasopoulou, A., Bran, D., Roozendaal, K.J., Noordijk, E.M., Musson, H., Teodorovic, L., Maes, B., Carbone, A., Carde, P. & Thomas, J. (2001) Standard chemotherapy with or without high-dose chemotherapy for aggressive non-Hodgkin's lymphoma: randomized phase III EORTC study. Journal of the National Cancer Institute, 93, 22-30.
21. Mantel, N. (1966) Evaluation of survival data and two new rank order statistics arising in its consideration. Cancer Chemotherapy Reports - Part 1, 50, 163-170.
22. Melnyk, A., Rodriguez, A., Pugh, W.C. & Cabannillas, F. (1997) Evaluation of the revised European-American lymphoma classification confirms the clinical relevance of immunophenotype in 560 cases of aggressive non-Hodgkin's lymphoma. Blood, 89, 4514-4520.
23. Philip, T., Guglielmi, C., Hagenbeek, A., Somers, R., Van der Lelie, H., Bron, D., Sonneveld, P., Gisselbrecht, C., Cahn, J.Y. & Harousseau, J.L. (1995) Autologous bone marrow transplantation as compared with salvage chemotherapy in relapses of chemotherapy-sensitive non-Hodgkin's lymphoma. New England Journal of Medicine, 333, 1540-1545.
24. Prince, H.M., Crump, M., Imrie, K., Stewart, A.K., Girouard, C., Brandwein, J.M., Carstairs, K., Pantalony, D., Scott, J.G., Sutcliffe, S., Sutton, D.M., Tsang, R. & Keating, A. (1996a) Intensive therapy and autotransplant for patients with an incomplete response to front-line therapy for lymphoma. Annals of Oncology, 7, 1043-1049.
25. Prince, H.M., Imrie, K., Crump, M., Stewart, A.K., Girouard, C., Colwill, R., Brandwein, J., Tsang, R.W., Scott, J.G., Sutton, D.M., Pantalony, D., Carstairs, K., Sutcliffe, S.B. & Keating, A. (1996b) The role of intensive therapy and autologous blood and marrow transplantation for chemotherapy-sensitive relapsed and primary refractory non-Hodgkin's lymphoma: identification of major prognostic groups. British Journal of Haematology, 94, 880-889.
26. Rodriguez, J., Munsell, M., Yazji, S., Hagemeister, F.B., Younes, A., Andersson, B., Giralt, S., Gajewski, J., de Lima, M., Couriel, D., Romaguera, J., Cabanillas, F.F., Champlin, R.E. & Khouri, I.F. (2001a) Impact of high-dose chemotherapy on peripheral T-cell lymphomas. Journal of Clinical Oncology, 19, 3766-3770.
27. Rodriguez, J., Caballero, M., Gutierrez, A., Sierra, J., Lopez-Guillermo, A., Martin, J., Sarra, J., kahueta, J.J., Rifon, J. & Conde, E. (2001b) Results of high dose chemotherapy and autologous stem cell transplant in patients with peripheral T-cell lymphoma. The Spanish Lymphoma Cooperative Group Experience (GEL/TAMO). Blood, 98, 680a.
28. Velasquez, W.S., Cabanillas, F., Salvador, P., McLaughlin, P., Fridrik, M., Tucker, S., Jagannath, S., Hagemeister, F.B., Redman, J.R. & Swan, F. (1988) Effective salvage therapy for lymphoma with cisplatin in combination with high-dose Ara-C and dexamethasone (DHAP). Blood, 71, 117-122.
29. Velasquez, W.S., McLaughlin, P., Tucker, S., Hagemeister, F.B., Swan, F., Rodriguez, M.A., Romaguera, J., Rubenstein, E. & Cabanillas, F. (1994) ESHAP - an effective chemotherapy regimen in refractory and relapsing lymphoma: a 4-year follow-up study. Journal of Clinical Oncology, 12, 1169-1176.
30. Vose, J.M., Bierman, P.J., Lynch, J.C., Weisenburger, D.D., Kessinger, A., Chan, W.C., Greiner, T.C. & Armitage, J.O. (1998) Effect of follicularity on autologous transplantation for large-cell non-Hodgkin's lymphoma. Journal of Clinical Oncology, 16, 844-849.
31. Vose, J.M., Peterson, C., Bierman, P.J., Weisenburger, D.D., Linder, J., Harrington, D., Vaughan, W.P., Kessinger, A. & Armitage, J.O. (1990) Comparison of high-dose therapy and autologous bone marrow transplantation for T-cell and B-cell non-Hodgkin's lymphomas. Blood, 76, 424-431.
32. Vose, J.M., Zhang, M.J., Rowlings, P.A., Lazarus, H.M., Bolwell, B.J., Freytes, C.O., Pavlovsky, S., Keating, A., Yanes, B., van Besien, K., Armitage, J.O., Horowitz, M.M. & Autologous Blood and Marrow Transplant Registry Lymphoma Working Committee (2001) Autologous transplantation for diffuse aggressive non-Hodgkm's lymphoma in patients never achieving remission: a report from the Autologous Blood and Marrow Transplant Registry. Journal of Clinical Oncology, 19, 406-413.